LISATA THERAPEUTICS, INC. Notes Payable, Current
LISATA THERAPEUTICS, INC. (LSTA) had Notes Payable, Current of $0 as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current
us-gaap:NotesPayableCurrent · last filed 2019-03-14
- 2018-12-31: Notes Payable, Current $0.00.
- 2018-09-30: Notes Payable, Current $0.00.
- 2018-06-30: Notes Payable, Current $23.29K.
- 2018-03-31: Notes Payable, Current $92.05K.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $23.29K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $92.05K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $159.00K 10-K · filed 2019-03-14 | $159.18K 10-K · filed 2018-03-22 |
| 2017-09-30 | $359.55K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $578.35K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $1.01M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $563.78K 10-K · filed 2018-03-22 | $847.33K 10-K · filed 2017-03-17 |
| 2016-09-30 | $745.23K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $1.01M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.36M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $1.19M 10-K · filed 2017-03-17 | |
| 2015-09-30 | $1.01M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $882.70K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.06M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $816.78K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $995.58K 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $794.24K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $836.22K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $381.10K 10-K · filed 2015-03-02 | |
| 2013-09-30 | $402.81K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $278.33K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $143.40K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $202.56K 10-K · filed 2014-03-13 | |
| 2012-09-30 | $135.22K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $154.98K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $254.39K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $148.06K 10-K · filed 2013-03-11 | |
| 2011-09-30 | $3.77M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $11.06M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $116.89K 8-K · filed 2012-08-15 | $9.57M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |